Filing Details
- Accession Number:
- 0001209191-14-031519
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-06 17:30:43
- Reporting Period:
- 2014-05-02
- Filing Date:
- 2014-05-06
- Accepted Time:
- 2014-05-06 16:30:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1554979 | E Megan Pace | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp, Corp. Communications | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-05-02 | 500 | $67.01 | 23,850 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-02 | 400 | $67.94 | 23,450 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-02 | 100 | $69.42 | 23,350 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1.
- Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $67.01 (range $66.49 to $67.40).
- Open market sales reported on this line occurred at a weighted average price of $67.94 (range $67.73 to $68.24).
Billionaire Hedge Funds
